Clinical Trial Update: Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of Phase 2 and Phase 3 trials evaluating various combinable magnetic resonance pulse sequences for macrophage imaging using …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• ferucarbotran (Resovist) (ferucarbotran)

Snippet

Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED